CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported second quarter 2015 financial results.
Revenue for the second quarter of 2015 was $7.6 million, an increase of 17% over the prior year period. During the quarter, 29 additional XT-8 analyzers were placed in end-user laboratories, resulting in a total installed base of 591 analyzers within the U.S. market.
Help employers find you! Check out all the jobs and post your resume.
